First Tracks Biotherapeutics (TRAXV) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 2 9 sessions, April 6, 2026 to April 17, 2026
- Largest daily move
- +27.4% close of April 8, 2026
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAXV) is classified in the biotechnology industry within the Healthcare sector.
TRAXV declined 4.2% in the week to April 17, 2026. The last closing price was $22.51.
This page collects what Stock Titan holds for TRAXV, including price data and SEC filings.
Stock Performance
First Tracks Biotherapeutics (TRAXV) closed at $22.51 on April 17, 2026. In the week to April 17, 2026, the price lost 4.2%.
Latest News
SEC Filings
First Tracks Biotherapeutics has filed 10 recent SEC filings, including 8 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAXV SEC filings →
TRAXV Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAXV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing TRAXV often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and Revolution Medicines, Inc. (RVMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TRAXV's relative position within its industry.